ArticleCancers2022
Circulating SOD2 Is a Candidate Response Biomarker for Neoadjuvant Therapy in Breast Cancer.
Mercè Juliachs et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ArticleCancers2022
Mercè Juliachs et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.